New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide
Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX
Unitaid statement on WHO recommendations for tocilizumab and sarilumab
Joint COVAX Statement on the equal recognition of vaccines
6 million children benefitting from the first ever multi-antigen vaccination campaign
Harare, 1 July 2021 – UNICEF, Gavi, the Vaccine Alliance and […]
ANNOUNCEMENT: New Alliance Chair, Professor Brendan Crabb AC
1 July 2021, Melbourne: The Australian Global Health Alliance […]
Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX
-
Indonesia introduces Pneumococcal Conjugate Vaccine (PCV) across the country
-
Gavi, UNICEF and partners collaborate on nationwide introduction, which […]
Gavi Board strengthens commitment to reaching the most vulnerable through routine immunisation and COVAX
-
Gavi Board makes key strategic decisions to support Gavi’s […]
Gavi and the Global Fund sign groundbreaking agreement with International Federation of Accountants to support in-country financial management
- Geneva, 24 June 2021 – Global health leaders Gavi, the […]